Robin L Jones

73PUBLICATIONS

279CO-AUTHORS

Molecular targetsComparative language studiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyGlobalisation and culture

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (73)

Sort by Publication Date:

|Jun 10, 2026

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

|May 04, 2026

Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort study.

|Apr 24, 2026

In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

|Mar 26, 2026

Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study.

Mrinal Gounder, Patrick Schöffski, Robin L Jones

|Jan 29, 2026

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.

Robin L Jones, Roman Groisberg, Jean-Yves Blay

|Jun 11, 2025

Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutions.

Stefania Kokkali, Ana Dolcan, Kjetil Boye

Pageof 13

Frequent Collaborators

19 joint publications

Paul Huang

12 joint publications

Jean-Yves Blay

Sebastian Bauer

Michael C Heinrich

Spyridon Gennatas

Brian A Van Tine

Margaret von Mehren

Javier Martín-Broto

Jonathan Trent

Winette T A van der Graaf

Frequent Collaborators

19 joint publications

Paul Huang

12 joint publications

Jean-Yves Blay

8 joint publications

Sebastian Bauer

8 joint publications

Michael C Heinrich